{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:16:56Z","timestamp":1780449416233,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.vaccine.2022.08.006","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T01:49:10Z","timestamp":1660009750000},"page":"5529-5536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Functional profiling of Covid 19 vaccine candidate by flow virometry"],"prefix":"10.1016","volume":"40","author":[{"given":"Ashley","family":"Prout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Rustandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0745-7818","authenticated-orcid":false,"given":"Christopher","family":"Tubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7918-103X","authenticated-orcid":false,"given":"Michael A.","family":"Winters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Vlasak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2022.08.006_b0005","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01765-17","article-title":"Flow virometry: a powerful tool to functionally characterize viruses","volume":"92","author":"Lipp\u00e9","year":"2018","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.006_b0010","doi-asserted-by":"crossref","DOI":"10.1002\/0471142956.cy1314s73","article-title":"Flow cytometry of extracellular vesicles: potential, pitfalls, and prospects","volume":"73","author":"Nolan","year":"2015","journal-title":"Curr Protocols Cytometry"},{"issue":"20","key":"10.1016\/j.vaccine.2022.08.006_b0015","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.vaccine.2016.03.067","article-title":"Use of flow cytometry for characterization of human cytomegalovirus vaccine particles","volume":"34","author":"Vlasak","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2022.08.006_b0020","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01600-19","article-title":"Intact viral particle counts measured by flow virometry provide insight into the infectivity and genome packaging efficiency of Moloney Murine Leukemia Virus","volume":"94","author":"Renner","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.08.006_b0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2015.10.021","article-title":"Evaluation of the maturation of individual Dengue virions with flow virometry","volume":"488","author":"Zicari","year":"2016","journal-title":"Virology"},{"issue":"24","key":"10.1016\/j.vaccine.2022.08.006_b0030","doi-asserted-by":"crossref","first-page":"14197","DOI":"10.1128\/JVI.01632-14","article-title":"Nipah virion entry kinetics, composition, and conformational changes determined by enzymatic virus-like particles and new flow virometry tools","volume":"88","author":"Landowski","year":"2014","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.006_b0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-00935-w","article-title":"Flow virometry analysis of envelope glycoprotein conformations on individual HIV virions","volume":"7","author":"Arakelyan","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2022.08.006_b0040","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01783-19","article-title":"Flow Cytometry Analysis of HIV-1 Env Conformations at the Surface of Infected Cells and Virions: Role of Nef, CD4, and SERINC5","volume":"94","author":"Staropoli","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.08.006_b0045","article-title":"Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273","volume":"8971900211009650","author":"Teo","year":"2021","journal-title":"J Pharm Pract"},{"issue":"7830","key":"10.1016\/j.vaccine.2022.08.006_b0050","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.vaccine.2022.08.006_b0055","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J Virol"},{"issue":"6511","key":"10.1016\/j.vaccine.2022.08.006_b0060","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Cai","year":"2020","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.vaccine.2022.08.006_b0065","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.cell.2021.02.032","article-title":"The antigenic anatomy of SARS-CoV-2 receptor binding domain","volume":"184","author":"Dejnirattisai","year":"2021","journal-title":"Cell"},{"issue":"7821","key":"10.1016\/j.vaccine.2022.08.006_b0070","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"issue":"6483","key":"10.1016\/j.vaccine.2022.08.006_b0075","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2022.08.006_b0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.006_b0085","doi-asserted-by":"crossref","first-page":"e1009246","DOI":"10.1371\/journal.ppat.1009246","article-title":"Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion","volume":"17","author":"Papa","year":"2021","journal-title":"PLoS Pathog"},{"issue":"35","key":"10.1016\/j.vaccine.2022.08.006_b0090","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"10.1016\/j.vaccine.2022.08.006_b0095","doi-asserted-by":"crossref","first-page":"10038","DOI":"10.1128\/JVI.76.19.10038-10043.2002","article-title":"Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccines","volume":"76","author":"Caulfield","year":"2002","journal-title":"J Virol"},{"issue":"5966","key":"10.1016\/j.vaccine.2022.08.006_b0100","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.1181766","article-title":"Cryo-EM model of the bullet-shaped vesicular stomatitis virus","volume":"327","author":"Ge","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.006_b0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-86688-z","article-title":"Flow virometry for process monitoring of live virus vaccines-lessons learned from ERVEBO","volume":"11","author":"Ricci","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2022.08.006_b0115","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/v13040562","article-title":"Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure","volume":"13","author":"Loveday","year":"2021","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.vaccine.2022.08.006_b0120","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02033-16","article-title":"Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH\/gL\/pUL128-131 Pentameric Complex","volume":"91","author":"Ha","year":"2017","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2200963X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2200963X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:16:06Z","timestamp":1759403766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2200963X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":23,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0264410X2200963X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional profiling of Covid 19 vaccine candidate by flow virometry","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}